Bronshoj, Denmark

Claus Kristensen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Claus Kristensen: Advancements in Lysosomal Enzymes

Introduction

Claus Kristensen, a notable inventor based in Bronshoj, Denmark, has made significant contributions to the field of biochemistry with his innovative work on lysosomal enzymes. With one patent to his name, Kristensen’s research reflects his commitment to advancing therapeutic solutions for complex health conditions.

Latest Patents

Kristensen's patent, titled "Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acid," encompasses a groundbreaking methodology involving lysosomal enzyme modifications. This invention focuses on enzymes altered via cell-based methods, which significantly improves their therapeutic efficacy. The modified enzymes exhibit low levels of Mannose-6-Phosphate and higher amounts of alpha2,3 sialic acid, facilitating long circulation times and enhanced uptake in challenging organs such as the heart, kidney, and brain.

Career Highlights

Throughout his career, Kristensen has collaborated with esteemed institutions, notably the University of Copenhagen and Glycodisplay ApS, enhancing his expertise in academic and practical applications of biochemistry. His work at these institutions has greatly influenced advancements in enzyme therapies, showcasing his dedication to innovative healthcare solutions.

Collaborations

In his journey as an inventor, Kristensen has worked closely with remarkable professionals such as Weihua Tian and Henrik Clausen. These collaborations have enriched his research endeavors, allowing for diverse perspectives and enhanced development of enzyme-based innovations.

Conclusion

Claus Kristensen’s inventive work in the field of lysosomal enzymes stands as a testament to the power of innovation in addressing complex medical challenges. His contributions pave the way for future advancements in enzymatic therapies, promising improved health outcomes for patients with difficult-to-treat conditions. As he continues to explore the potential of modified enzymes, the impact of his research will resonate in the biochemistry community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…